[{"id":"4ec6aa27-3db0-4988-ad1b-af35a4aa997e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05583201","created_at":"2022-10-17T13:56:08.698Z","updated_at":"2024-07-02T16:35:56.294Z","phase":"Phase 1","brief_title":"NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors","source_id_and_acronym":"NCT05583201","lead_sponsor":"jianming xu","biomarkers":" CLDN18","pipe":"","alterations":" ","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KD-496"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 10/13/2022","start_date":" 10/13/2022","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 06/01/2026","study_completion_date":" 06/01/2026","last_update_posted":"2023-02-07"}]